# Non-invasive BCI and Application Verification for Depressed People

> **NCT06417437** · PHASE4 · RECRUITING · sponsor: **Shanghai Mental Health Center** · enrollment: 400 (estimated)

## Conditions studied

- Depression
- Major Depressive Disorder
- Bipolar Depression

## Interventions

- **DRUG:** SSRI
- **DEVICE:** rTMS
- **BEHAVIORAL:** Neuro-Feedback
- **BEHAVIORAL:** Game Regulation

## Key facts

- **NCT ID:** NCT06417437
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06417437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06417437, "Non-invasive BCI and Application Verification for Depressed People". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06417437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
